Filters
Term Search
You can select from the dropdown list OR enter your own terms to refine the search.
Last Updated: 10/31/2025
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 239 publications
Limited pre-clinical relevance of the heterozygous RYR1-I4895T/+ mouse model due to its mild phenotype.
Journal: Journal of neuromuscular diseases
Published: September 19, 2025
A systematic review on motor outcome measures in congenital myopathy.
Journal: Neuromuscular disorders : NMD
Published: February 26, 2025
Clinical features and genetic analysis of a child with Central core disease due to compound heterozygous variants of RYR1 gene
Journal: Zhonghua yi xue yi chuan xue za zhi = Zhonghua yixue yichuanxue zazhi = Chinese journal of medical genetics
Published: April 29, 2024
Generation of two iPSC lines from patients with inherited central core disease and concurrent malignant hyperthermia caused by dominant missense variants in the RYR1 gene.
Journal: Stem cell research
Published: March 26, 2024
Case report: A creatine kinase-borg scale values-based approach to tailor physical training in a central core myopathy patient.
Journal: Frontiers in physiology
Published: March 21, 2024
Report of joint hypermobility in malignant hyperthermia susceptible patients: Observational study with a case-control descriptive design.
Journal: Heliyon
Published: March 13, 2024
Functional benefit of CRISPR-Cas9-induced allele deletion for RYR1 dominant mutation.
Journal: Molecular therapy. Nucleic acids
Published: February 08, 2024
Perioperative management of bronchoscopy in a child patient with central core disease: A case report and literature review.
Journal: International journal of surgery case reports
Published: January 23, 2024
Anesthetic Management of a Patient With Central Core Disease Undergoing Thoracoscopic Lung Resection: The Importance of Neuromuscular Monitoring at the Masseter Muscle.
Journal: Cureus
Published: January 17, 2024
A case report of central core disease with repeated foaming at the mouth as the initial symptom.
Journal: Medicine
Published: December 05, 2023
Rycal S48168 (ARM210) for RYR1-related myopathies: a phase one, open-label, dose-escalation trial.
Journal: EClinicalMedicine
Published: November 06, 2023
Last Updated: 10/31/2025